169 related articles for article (PubMed ID: 9875197)
21. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
Lim JL; Stern RS
J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
[TBL] [Abstract][Full Text] [Related]
22. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis.
Hannuksela-Svahn A; Sigurgeirsson B; Pukkala E; Lindelöf B; Berne B; Hannuksela M; Poikolainen K; Karvonen J
Br J Dermatol; 1999 Sep; 141(3):497-501. PubMed ID: 10583054
[TBL] [Abstract][Full Text] [Related]
23. The role of PUVA in the treatment of psoriasis. Photobiology issues related to skin cancer incidence.
Gasparro FP
Am J Clin Dermatol; 2000; 1(6):337-48. PubMed ID: 11702610
[TBL] [Abstract][Full Text] [Related]
24. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
[TBL] [Abstract][Full Text] [Related]
25. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
Stern RS
Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
[TBL] [Abstract][Full Text] [Related]
26. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study.
Nijsten TE; Stern RS
J Am Acad Dermatol; 2003 Oct; 49(4):644-50. PubMed ID: 14512910
[TBL] [Abstract][Full Text] [Related]
27. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy.
Park HS; Lee YS; Chun DK
J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):578-80. PubMed ID: 12941100
[TBL] [Abstract][Full Text] [Related]
28. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
[TBL] [Abstract][Full Text] [Related]
29. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
Henseler T; Christophers E; Hönigsmann H; Wolff K
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
[TBL] [Abstract][Full Text] [Related]
30. Minimising the risks of PUVA treatment.
van Praag MC; Tseng LN; Mommaas AM; Boom BW; Vermeer BJ
Drug Saf; 1993 May; 8(5):340-9. PubMed ID: 8504016
[TBL] [Abstract][Full Text] [Related]
31. Side-effects of psoralen photochemotherapy (PUVA).
Wolff K
Br J Dermatol; 1990 Jun; 122 Suppl 36():117-25. PubMed ID: 2196078
[TBL] [Abstract][Full Text] [Related]
32. Presence of Hand Warts Is Associated with Subsequent Development of Cutaneous Squamous Cell Carcinoma in Psoriasis Patients Treated with Psoralen UVA (PUVA).
Wu PA; Chen CA; Stern RS
J Invest Dermatol; 2016 Nov; 136(11):2317-2319. PubMed ID: 27456757
[No Abstract] [Full Text] [Related]
33. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
34. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. An 8-year follow-up study.
Tanew A; Hönigsmann H; Ortel B; Zussner C; Wolff K
J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):960-5. PubMed ID: 3782536
[TBL] [Abstract][Full Text] [Related]
35. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study.
Stern RS; Nichols KT
J Pediatr; 1996 Dec; 129(6):915-7. PubMed ID: 8969737
[TBL] [Abstract][Full Text] [Related]
36. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
37. PUVA and cancer: a large-scale epidemiological study.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Christensen OB; Andersson T; Törngren M; Molin L
Lancet; 1991 Jul; 338(8759):91-3. PubMed ID: 1676477
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous neoplasia following PUVA therapy for psoriasis.
McKenna KE; Patterson CC; Handley J; McGinn S; Allen G
Br J Dermatol; 1996 Apr; 134(4):639-42. PubMed ID: 8733363
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. A preliminary report.
Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Berne B
Arch Dermatol; 1992 Oct; 128(10):1341-4. PubMed ID: 1417020
[TBL] [Abstract][Full Text] [Related]
40. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
